GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » 1-Year ROIIC %

Pharmagreen Biotech (Pharmagreen Biotech) 1-Year ROIIC % : 2,315.38% (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Pharmagreen Biotech's 1-Year ROIIC % for the quarter that ended in Jun. 2023 was 2,315.38%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Pharmagreen Biotech's 1-Year ROIIC % or its related term are showing as below:

PHBI's 1-Year ROIIC % is ranked better than
98.8% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 1.23 vs PHBI: 2315.38

Pharmagreen Biotech 1-Year ROIIC % Historical Data

The historical data trend for Pharmagreen Biotech's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech 1-Year ROIIC % Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
1-Year ROIIC %
Get a 7-Day Free Trial - 31.22 10.43 19.69 146.08

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,140.00 146.08 358.62 -90.67 2,315.38

Competitive Comparison of Pharmagreen Biotech's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmagreen Biotech's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's 1-Year ROIIC % falls into.



Pharmagreen Biotech 1-Year ROIIC % Calculation

Pharmagreen Biotech's 1-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -0.558 (Jun. 2023) - -1.16 (Jun. 2022) )/( 0.641 (Jun. 2023) - 0.615 (Jun. 2022) )
=0.602/0.026
=2,315.38%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Pharmagreen Biotech  (OTCPK:PHBI) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Pharmagreen Biotech 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.